Catalyst Wire Dossier Catalyst Wire Dossier

Leuprolide mesylate

leuprolide mesylate · Foresee Pharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Leuprolide mesylate, covering 2018-04-13 to 2026-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty [Phase 3]

See pricing